Latest H5N1 clinical trials Stories
WORCESTER, Mass., Sept. 16 /PRNewswire/ -- Generex Biotechnology Corporation (NasdaqCM: GNBT; www.generex.com) today announced presentations in respect of the technologies and development products of its wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com).
SWIFTWATER, Pa., Sept. 13 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S.
SWIFTWATER, Pa., July 30 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that shipping of the 2010-2011 formulation of its seasonal influenza vaccine FluzoneÂ® Influenza Virus Vaccine is underway in the U.S.
PHILADELPHIA, July 30 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLavalÂ® [Influenza Virus Vaccine] allowing distribution in the U.S.
University of Miami researcher uses computer programs to develop a fast and efficient method of generating vaccines for new strains of flu viruses.
ROCKVILLE, Md., July 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointment of Gregory Glenn, M.D., as the company's Chief Scientific Officer who will report to Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax. Previously, Dr.
ROCKVILLE, Md., June 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointments of John W. Madsen, Ph.D., as Head of Process and Manufacturing Operations and Steven Pincus, Ph.D., as Head of Analytical and Quality Operations. Dr.
Researchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots.
Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations.
ROCKVILLE, Md., May 13 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announces the first report of a vaccine protecting ferrets against the 2009 pandemic H1N1 virus has been published in the journal Vaccine May 12, 2010 online issue.
- The parings of haberdine; also, any kind of fragments.